Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind

Authors not listed

Columbia University · 2017

Abstract

The purpose of this project is to study brain imaging of a substance called tau, which is found in brains of persons with Alzheimer's disease, using the Tau binder, 18F-THK-5351, for live imaging of tau in the brain. The main goal of this proposal is to study whether diabetes status (type 2 diabetes \[referred to as diabetes\] and pre-diabetes, compared with normal glucose tolerance \[NGT\]), is associated with increased tau accumulation in the brain, one of the culprits of Alzheimer's disease, in a community-based group of middle aged Caribbean-Hispanics with a mean age of 63 years. The investigators propose to conduct tau positron emission tomography (PET) imaging in 30 middle aged Hispanics.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-13 MST

Cite this

APA
Anonymous. (2017). TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind. <em>Columbia University</em>. https://clinicaltrials.gov/study/NCT03024944
Vancouver
Anonymous. TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind. Columbia University. 2017.
BibTeX
@misc{anon2017TAUPET, title = {TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind}, author = {Anonymous}, journal = {Columbia University}, year = {2017}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings